| Literature DB >> 36059925 |
Yuting Su1,2, Yao Peng1,2, Jie Ren1,2, Shangjie Wu3, Si Lei3, Fei Peng3, Zhina Sun4, Xiuqing He4, Juan Li1,2, Shunxiang Li1,2.
Abstract
Berberidis Cortex is rich in alkaloids, and many of them have antibacterial, anti-inflammatory, and hypoglycemic activities. However, few research studies have focused on the quantitative analysis of multiple components from Berberidis Cortex. In this study, a new quality evaluation strategy for Berberidis Cortex was developed and validated by high-performance liquid chromatography (HPLC), which involved single marker, fingerprint, and stoichiometric methods. Using berberine hydrochloride as an internal reference, the relative correction factors of palmatine hydrochloride, magnoline, and jatrorrhizine hydrochloride were 2.4537, 0.9783, and 1.0035, respectively, and their durabilities were also well performed. In addition, both methods mentioned above were used to compare the mass fractions of four isoquinoline alkaloids in ten batches of Berberidis Cortex from different origins. These results indicated that the approach applied in this study was accurate and feasible. The fingerprints of these ten batches of Berberidis Cortex were established, and eleven components were identified with the similarity greater than 0.993. Both cluster and principal component analysis were carried out based on the peak area of these components, the results demonstrated that these ten batches of Berberidis Cortex were divided into two groups and the distribution of the medicinal material was basically consistent. Therefore, quantitative analysis of multicomponents by single marker (QAMS) can be widely used in the quality control of Berberidis Cortex as theoretical basis.Entities:
Year: 2022 PMID: 36059925 PMCID: PMC9436626 DOI: 10.1155/2022/8042631
Source DB: PubMed Journal: J Anal Methods Chem ISSN: 2090-8873 Impact factor: 2.594
Figure 1The chemical structure of four alkaloid compounds. (a) Magnoflorine; (b) jatrorrhizine hydrochloride; (c) palmatine hydrochloride; (d) berberine hydrochloride.
The source information of the samples.
| Number | Origins | Date of collection |
|---|---|---|
| S1 | Xining, Qinghai | 2019.06 |
| S2 | Xining, Qinghai | 2019.10 |
| S3 | Huangnan, Qinghai | 2020.08 |
| S4 | Huangnan, Qinghai | 2020.10 |
| S5 | Qilian, Qinghai | 2020.08 |
| S6 | Qilian, Qinghai | 2020.10 |
| S7 | Tongren, Qinghai | 2020.09 |
| S8 | Tongren, Qinghai | 2020.10 |
| S9 | Zeku, Qinghai | 2020.09 |
| S10 | Zeku, Qinghai | 2020.10 |
Calibration curves of four alkaloids of the reference substance.
| Analytes | Regression equation | R | LOD (mg/mL) | LOQ (mg/mL) | Linear range (mg/mL) |
|---|---|---|---|---|---|
| Magnoflorine |
| 0.9999 | 0.0113 | 0.0377 | 0.0780∼1.550 |
| Jatrorrhizine hydrochloride |
| 0.9999 | 0.0056 | 0.0185 | 0.0440∼0.8700 |
| Palmatine hydrochloride |
| 0.9999 | 0.0055 | 0.0182 | 0.0380∼0.7600 |
| Berberine hydrochloride |
| 1.000 | 0.0044 | 0.0145 | 0.0500∼1.000 |
Figure 2Chromatograms of the standard solutions and sample solutions. (a) Mixed standard solution; (b) sample solution; (1) magnoflorine; (2) jatrorrhizine hydrochloride; (3) palmatine hydrochloride; (4) berberine hydrochloride.
Taking the berberine hydrochloride as the internal standard to calculate the RCF values.
| Injection volume ( |
|
|
|
|---|---|---|---|
| 10 | 2.4742 | 0.9914 | 1.0084 |
| 8 | 2.4476 | 0.9837 | 1.0039 |
| 6 | 2.4480 | 0.9831 | 0.9975 |
| 4 | 2.4433 | 0.9768 | 0.9990 |
| 2 | 2.4476 | 0.9664 | 1.0047 |
| 1 | 2.4614 | 0.9682 | 1.0072 |
| Mean | 2.4537 | 0.9783 | 1.0035 |
| RSD (%) | 0.48 | 0.99 | 0.38 |
f s/A: fBerberine hydrochloride/magnoflorine; f: fBerberine hydrochloride/jatrorrhizine hydrochloride; f: fBerberine hydrochloride/palmatine hydrochloride.
Taking the berberine hydrochloride as the internal standard to calculate the RRT values.
| Factors | Chromatographic columns |
|
|
|
|---|---|---|---|---|
| Waters 2695 | CAPCELL PAK C18 | 0.4970 | 0.8434 | 0.9621 |
| Phenomenex luna C18 | 0.4802 | 0.8497 | 0.9655 | |
| Venusil XBP C18 | 0.4910 | 0.8530 | 0.9664 | |
| Waters acquity | CAPCELL PAK C18 | 0.4694 | 0.8463 | 0.9675 |
| Phenomenex luna C18 | 0.4693 | 0.8463 | 0.9675 | |
| Venusil XBP C18 | 0.4638 | 0.8576 | 0.9741 | |
| Mean | 0.4784 | 0.8494 | 0.9672 | |
| RSD (%) | 2.8 | 0.61 | 0.41 |
The RCF values of three alkaloids in different conditions.
| Chromatographic condition | Factors | Chromatographic columns |
|
|
|
|---|---|---|---|---|---|
| Column | Waters 2695 | CAPCELL PAK C18 | 2.4867 | 0.9971 | 1.0096 |
| Phenomenex luna C18 | 2.5126 | 0.9975 | 1.0179 | ||
| Venusil XBP C18 | 2.4742 | 0.9914 | 1.0077 | ||
| Waters ACQUITY | CAPCELL PAK C18 | 2.4459 | 0.9849 | 0.9938 | |
| Phenomenex luna C18 | 2.4908 | 0.9825 | 1.0169 | ||
| Venusil XBP C18 | 2.4175 | 0.9762 | 0.9867 | ||
| Mean | 2.4713 | 0.9883 | 1.0054 | ||
| RSD (%) | 1.4 | 0.86 | 1.3 | ||
| Column temperature | 20°C | 2.4394 | 0.9840 | 1.0026 | |
| 25°C | 2.4489 | 0.9962 | 1.0028 | ||
| 30°C | 2.4447 | 0.9876 | 1.0037 | ||
| 35°C | 2.4315 | 0.9683 | 0.9978 | ||
| Mean | 2.4411 | 0.9840 | 1.002 | ||
| RSD (%) | 0.31 | 1.2 | 0.27 |
Comparision of the results from the ESM and QAMS (mg g−1) (n = 3).
| Sample | Magnoflorine (mg·g−1) | Jatrorrhizine hydrochloride (mg·g−1) | Palmatine hydrochloride (mg·g−1) | Berberine hydrochloride (mg·g−1) | |||
|---|---|---|---|---|---|---|---|
| ESM | QAMS | ESM | QAMS | ESM | QAMS | ESM | |
| S1 | 72.054 | 72.997 | 4.4788 | 4.4383 | 3.0232 | 3.0468 | 30.684 |
| S2 | 69.421 | 70.329 | 4.7649 | 4.7155 | 3.2925 | 3.3037 | 30.551 |
| S3 | 59.079 | 59.852 | 3.9308 | 3.8901 | 3.0882 | 3.0987 | 29.654 |
| S4 | 57.634 | 58.390 | 3.8432 | 3.8034 | 3.029 | 3.0393 | 28.76 |
| S5 | 55.062 | 55.783 | 2.5538 | 2.5274 | 4.0719 | 4.0858 | 25.312 |
| S6 | 55.69 | 56.418 | 2.6996 | 2.6717 | 4.0044 | 4.018 | 23.541 |
| S7 | 57.297 | 58.046 | 6.8179 | 6.7473 | 3.4486 | 3.4603 | 23.705 |
| S8 | 57.608 | 58.362 | 6.9338 | 6.862 | 3.3088 | 3.3200 | 23.197 |
| S9 | 60.988 | 61.786 | 4.0477 | 4.0058 | 3.2511 | 3.2621 | 31.403 |
| S10 | 62.747 | 63.569 | 4.0798 | 4.0376 | 3.3541 | 3.3655 | 32.401 |
Figure 3HPLC fingerprints of the ten batches of Berberidis Cortex.
Figure 4Clustering analysis of ten batches of Berberidis Cortex from different origins.
Figure 5The heat map analysis of ten batches of Berberidis Cortex.
Figure 6(a) The PCA score scatter plots of samples. (b) The PCA scatter 3D plot of samples. (c) Scree plot. (d) Samples in planar distribution of three dimensions
Characteristic value and variance contribution rate.
| Component | Initial eigenvalues | Extraction sums of squared loadings | ||||
|---|---|---|---|---|---|---|
| Total | % of variance | Cumulative % | Total | % of variance | Cumulative % | |
| 1 | 4.869 | 44.260 | 44.260 | 4.869 | 44.260 | 44.260 |
| 2 | 2.906 | 26.420 | 70.679 | 2.906 | 26.420 | 70.679 |
| 3 | 2.333 | 21.210 | 91.890 | 2.333 | 21.210 | 91.890 |